Testmiljö
Observera att detta är en testmiljö för utveckling som inte ska användas som underlag för klinisk bedömning. Besök Janusmed här: https://janusmed.se

11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Vaccin mot stelkramp

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
1 1
1 1

Vaccin mot stelkramp Testmiljö

Vaccin mot stelkramp

Klass : 1

Visa all info

Skriv ut

Kontakta oss

  1. Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol. 2020;0(0):1-18.

  2. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group, Littleton, Mass. 1977.

  3. Psarris A, Sindos M, Daskalakis G, Chondrogianni ME, Panayiotou S, Antsaklis P et al. Immunizations during pregnancy: How, when and why. Eur J Obstet Gynecol Reprod Biol. 2019;240(0):29-35.

  4. Sukumaran L, McCarthy NL, Kharbanda EO, McNeil MM, Naleway AL, Klein NP et al. Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations. JAMA. 2015;314(15):1581-7.

  5. Griffin JB, Yu L, Watson D, Turner N, Walls T, Howe AS et al. Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine. Vaccine. 2018;36(34):5173-5179.

  6. Laverty M, Crowcroft N, Bolotin S, Hawken S, Wilson K, Amirthalingam G et al. Health Outcomes in Young Children Following Pertussis Vaccination During Pregnancy. Pediatrics. 2021;147(5):0.

  7. Switzer C, Tikhonov I, Khromava A, Pool V, Lévesque LE. Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry. Hum Vaccin Immunother. 2021;1-9.

  1. Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol. 2020;0(0):1-18.
  2. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group, Littleton, Mass. 1977.
  3. Psarris A, Sindos M, Daskalakis G, Chondrogianni ME, Panayiotou S, Antsaklis P et al. Immunizations during pregnancy: How, when and why. Eur J Obstet Gynecol Reprod Biol. 2019;240(0):29-35.
  4. Sukumaran L, McCarthy NL, Kharbanda EO, McNeil MM, Naleway AL, Klein NP et al. Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations. JAMA. 2015;314(15):1581-7.
  5. Griffin JB, Yu L, Watson D, Turner N, Walls T, Howe AS et al. Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine. Vaccine. 2018;36(34):5173-5179.
  6. Laverty M, Crowcroft N, Bolotin S, Hawken S, Wilson K, Amirthalingam G et al. Health Outcomes in Young Children Following Pertussis Vaccination During Pregnancy. Pediatrics. 2021;147(5):0.
  7. Switzer C, Tikhonov I, Khromava A, Pool V, Lévesque LE. Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry. Hum Vaccin Immunother. 2021;1-9.